153 related articles for article (PubMed ID: 6300400)
21. Properties of [3H] beta-carboline-3-carboxylate ethyl ester binding to the benzodiazepine receptor.
Marangos PJ; Patel J
Life Sci; 1981 Oct; 29(16):1705-14. PubMed ID: 6273677
[No Abstract] [Full Text] [Related]
22. Modulation of GABA binding to rat brain membranes by alkyl beta-carboline-3-carboxylate esters.
Skerritt JH; Johnston GA; Braestrup C
Eur J Pharmacol; 1982 Dec; 86(2):299-301. PubMed ID: 6897636
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of some transition metal cations on the binding of beta-carboline-3-carboxylate and diazepam.
Mizuno S; Ogawa N; Mori A
Neurochem Res; 1983 Jul; 8(7):873-80. PubMed ID: 6312349
[TBL] [Abstract][Full Text] [Related]
24. Isolation and identification in bovine cerebral cortex of n-butyl beta-carboline-3-carboxylate, a potent benzodiazepine binding inhibitor.
Peña C; Medina JH; Novas ML; Paladini AC; De Robertis E
Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4952-6. PubMed ID: 3014522
[TBL] [Abstract][Full Text] [Related]
25. Ethyl beta-carboline-3-carboxylate shows differential benzodiazepine receptor interaction.
Nielsen M; Braestrup C
Nature; 1980 Aug; 286(5773):606-7. PubMed ID: 6250077
[TBL] [Abstract][Full Text] [Related]
26. Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site.
Allen MS; Tan YC; Trudell ML; Narayanan K; Schindler LR; Martin MJ; Schultz C; Hagen TJ; Koehler KF; Codding PW
J Med Chem; 1990 Sep; 33(9):2343-57. PubMed ID: 2167977
[TBL] [Abstract][Full Text] [Related]
27. N-(indol-3-ylglyoxylyl)amino acid ester derivatives. Synthesis and interaction properties at the benzodiazepine receptor.
Primofiore G; Da Settimo F; Marini AM; La Motta C; Martini C; Senatore G; Lucacchini A
Farmaco; 1995 Jan; 50(1):5-12. PubMed ID: 7702721
[TBL] [Abstract][Full Text] [Related]
28. Isosteric replacement of amide by ester function. Synthesis and benzodiazepine receptor affinity of indol-3-ylglyoxylyl ester derivatives.
Da Settimo A; Primofiore G; Marini AM; Da Settimo F; Nuti V; Martini C; Trincavelli L; Lucacchini A
Farmaco; 1997; 52(6-7):421-8. PubMed ID: 9372593
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
Yin W; Majumder S; Clayton T; Petrou S; VanLinn ML; Namjoshi OA; Ma C; Cromer BA; Roth BL; Platt DM; Cook JM
Bioorg Med Chem; 2010 Nov; 18(21):7548-64. PubMed ID: 20888240
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity studies of beta-carboline analogs.
Lawson JA; Uyeno ET; Nienow J; Loew GH; Toll L
Life Sci; 1984 May; 34(21):2007-13. PubMed ID: 6328151
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of benzodiazepine receptors: experimental differences between [3H]flunitrazepam and [3H]ethyl-beta-carboline-3-carboxylate binding sites in rat brain membranes.
Medina JH; Novas ML; De Robertis E
J Neurochem; 1983 Sep; 41(3):703-9. PubMed ID: 6135757
[No Abstract] [Full Text] [Related]
32. Interactions of beta-carbolines with the benzodiazepine receptor: structure-activity relationships.
Robertson HA; Baker GB; Coutts RT; Benderly A; Locock RA; Martin IL
Eur J Pharmacol; 1981 Dec; 76(2-3):281-4. PubMed ID: 6277646
[TBL] [Abstract][Full Text] [Related]
33. Pre- versus postsynaptic localization of benzodiazepine and beta-carboline binding sites.
Tietz EI; Chiu TH; Rosenberg HC
J Neurochem; 1985 May; 44(5):1524-34. PubMed ID: 2985753
[TBL] [Abstract][Full Text] [Related]
34. Ivermectin interactions with benzodiazepine receptors in rat cortex and cerebellum in vitro.
Williams M; Risley EA
J Neurochem; 1984 Mar; 42(3):745-53. PubMed ID: 6319606
[TBL] [Abstract][Full Text] [Related]
35. n-[3H]butyl-beta-carboline-3-carboxylate, a putative endogenous ligand, binds preferentially to subtype 1 of central benzodiazepine receptors.
Medina JH; de Stein ML; De Robertis E
J Neurochem; 1989 Mar; 52(3):665-70. PubMed ID: 2537375
[TBL] [Abstract][Full Text] [Related]
36. Differential pharmacological effects of beta-carboline-3-carboxylic acid esters.
Oakley NR; Jones BJ
Neuropharmacology; 1982 Jun; 21(6):587-9. PubMed ID: 6896745
[TBL] [Abstract][Full Text] [Related]
37. Binding of [3H]ethyl-beta-carboline-3-carboxylate to brain benzodiazepine receptors: effect of drugs and anions.
Williams EF; Paul SM; Rice KC; Cain M; Skolnick P
FEBS Lett; 1981 Sep; 132(2):269-72. PubMed ID: 6271593
[No Abstract] [Full Text] [Related]
38. Photolabeling of benzodiazepine receptors spares [3H]propyl beta-carboline binding.
Hirsch JD
Pharmacol Biochem Behav; 1982 Feb; 16(2):245-8. PubMed ID: 6280201
[TBL] [Abstract][Full Text] [Related]
39. Binding of beta-carbolines and caffeine on benzodiazepine receptors: correlations to convulsions and tremor.
Saano V; Airaksinen MM
Acta Pharmacol Toxicol (Copenh); 1982 Oct; 51(4):300-8. PubMed ID: 6295064
[TBL] [Abstract][Full Text] [Related]
40. Tofizopam selectively increases the affinity of benzo-diazepine binding sites for [3H]flunitrazepam but not for beta [3H] carboline-3-carboxylic acid ethyl ester.
Saano V
Pharmacol Res Commun; 1982 Nov; 14(10):971-81. PubMed ID: 6130533
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
